Report
Jonathan Moreland
EUR 8.70 For Business Accounts Only

Daily Insider Ratings Report: Mar 21, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Acacia Communications Inc.

Acacia Communications is a provider of coherent optical interconnect products. The company's products fall into three product groups: embedded modules, pluggable modules and semiconductors. The company's embedded module and pluggable module product groups consist of optical interconnect modules for use in long-haul, metro and inter-data center markets. The company's semiconductor product group consists of its low-power coherent digital signal processor application-specific integrated circuits and its silicon photonic integrated circuits which are either integrated into its embedded and pluggable modules or sold to customers on a standalone basis for integration into internally developed or other merchant modules.

Achaogen Inc.

Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The company develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. The company also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae.

CASI Pharmaceuticals

CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products. The company's primary product and candidates in hematology/oncology include: EVOMELA (Melphalan for Injection), an intravenous formulation of melphalan commercialized in the multiple myeloma treatment setting in the United States; CNCT19, which targets CD19, a B-cell surface protein expressed during all phases of B-cell development and a validated target for B-cell driven hematological malignancies; CID-103, an investigational anti-CD38 monoclonal antibody being developed for the treatment of patients with multiple myeloma.

FS KKR Capital Corp.

FS KKR Capital is an externally managed, non-diversified, closed-end management investment company. The company is managed by FS/KKR Advisor, LLC, an investment adviser, which oversees the management of the company's operations. The company's portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans of private U.S. companies. The company may purchase interests in loans or make other debt investments, including investments in senior secured bonds, through secondary market transactions in the over-the-counter, market or directly from its target companies as primary market or directly originated investments.

Legacy Reserves

Legacy Reserves is engaged in the acquisition and development of oil and natural gas properties. The company owns and operates oil and natural gas producing properties located primarily in East Texas, the Permian Basin (West Texas and Southeast New Mexico), Rocky Mountain and Mid-Continent regions of the United States. The company is focused on two activities: the acquisition of producing oil and natural gas properties and the development of properties in established producing trends. As of Dec 31 2016, the company had proved reserves of 144.8 million barrels of oil equivalent, consisting of 32.5 million barrels of oil, 7.8 million barrels of natural gas liquids, and 627 billion cubic feet of natural gas.

OPKO Health Inc.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Prospect Capital Corporation

Prospect Capital is a financial services company that primarily lends to and invests in middle market privately-held companies. The company is a closed-end investment company. The company's investment objective is to generate both income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies in need of capital for acquisitions, divestitures, growth, development, recapitalizations and other purposes.

Snap Inc. Class A

Snap is a camera company. The company's primary product, Snapchat, is a camera application that helps people to communicate visually through short videos and images called Snaps. The company's products are: Camera, which includes tools for people to personalize their Snaps; Chat, which includes interacting with friends on Snapchat; Discover, which includes providing Stories and Shows from publishers, creators, and the community; Snap Map, which shows a live map of the user's location; Memories, which enables users to save the Snaps they create in a personal collection called Memories; and Spectacles, which includes creating Memories by using Spectacles, which are the company's sunglasses that make Snaps.

Universal Insurance Holdings Inc.

Universal Insurance Holdings is a holding company. Through its subsidiaries, the company provides property and casualty insurance and insurance services. The company's products and services include: Insurance Products, which provide various types of personal residential insurance such as homeowners, renters/tenants, condo unit owners, and dwelling/fire; Risk Management, in which its subsidiary, Evolution Risk Advisors, Inc., advises on actuarial issues, oversees distribution, administers claims payments, performs policy administration and underwriting, and assists with reinsurance negotiations; and Distribution, which provides policies through its direct-to-consumer online distribution platforms.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch